about
Y-chromosomal diversity in Europe is clinal and influenced primarily by geography, rather than by language9p21 locus rs10757278 is associated with advanced carotid atherosclerosis in a gender-specific manner.Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke.Transcriptome-wide based identification of miRs in congenital anomalies of the kidney and urinary tract (CAKUT) in children: the significant upregulation of tissue miR-144 expression.CXCL16 in Vascular Pathology Research: from Macro Effects to microRNAs.The Interaction of Apolipoprotein E and Angiotensin I-Converting Enzyme Dna Polymorphisms with Hypertension on Early Ischemic Stroke Risk.Angiotensin receptor type 1 polymorphism A1166C is associated with altered AT1R and miR-155 expression in carotid plaque tissue and development of hypoechoic carotid plaques.Renin-angiotensin system gene polymorphisms as risk factors for multiple sclerosis.CXCL16 haplotypes in patients with human carotid atherosclerosis: preliminary results.Plasma levels of matrix metalloproteinase-8 in patients with carotid atherosclerosis.A simple PCR with different 3' ends of the third primer for detection of defined point mutations: HCV genotyping as an example.Expression profiling of the AT2R mRNA in affected tissue from children with CAKUT.ACE and AT1 receptor gene polymorphisms and renal scarring in urinary bladder dysfunction.Effects of glutathione S-transferase T1 and M1 deletions on advanced carotid atherosclerosis, oxidative, lipid and inflammatory parameters.Matrix metalloproteinase-1 promoter genotypes and haplotypes are associated with carotid plaque presence.The HACD4 haplotype as a risk factor for atherosclerosis in males.Regulation of hepatic Na(+)/K(+)-ATPase in obese female and male rats: involvement of ERK1/2, AMPK, and Rho/ROCK.Changes in cardiac Na+/K+-ATPase expression and activity in female rats fed a high-fat diet.Gender-Specific Association between Angiotensin II Type 2 Receptor -1332 A/G Gene Polymorphism and Advanced Carotid Atherosclerosis.The gender-specific association of CXCL16 A181V gene polymorphism with susceptibility to multiple sclerosis, and its effects on PBMC mRNA and plasma soluble CXCL16 levels: preliminary findings.Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study.Endothelial NOS G894 T and MMP-3 5A/6A gene polymorphisms and hypertension in Serbian population.Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.Association of MMP-8 promoter gene polymorphisms with carotid atherosclerosis: preliminary study.Interleukin 7 receptor alpha polymorphism rs6897932 and susceptibility to multiple sclerosis in the Western Balkans.AT1 receptor A1166C and AT2 receptor -1332A/G gene polymorphisms: efficient genotyping by single-tube PCR.Association of polymorphisms in CTLA-4, IL-1ra and IL-1beta genes with multiple sclerosis in Serbian populationLipoprotein lipase: A bioinformatics criterion for assessment of mutations as a risk factor for cardiovascular diseaseApolipoprotein e gene polymorphism as a risk factor for ischemic cerebrovascular diseaseAngiotensin II type 1 receptor gene polymorphism and essential hypertension in Serbian populationAssociation of lipoprotein lipase gene Asn291Ser DNA polymorphism with plasma lipid levels and blood pressure levels in healthy population of SerbiaLeft ventricular remodeling after the first myocardial infarction in association with LGALS-3 neighbouring variants rs2274273 and rs17128183 and its relative mRNA expression: a prospective studyTranscriptome-driven integrative exploration of functional state of ureter tissue affected by CAKUTThe association of ACE I/D gene polymorphism with severe carotid atherosclerosis in patients undergoing carotid endarterectomyThe association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclerosisAssociation of MMP-3 5A/6A gene polymorphism with susceptibility to carotid atherosclerosisX-linked angiotensin II type 2 receptor gene polymorphism −1332A/G in male patients with essential hypertensionApolipoprotein(a) gene polymorphisms (TTTTA)n and G/A-914 affect Lp(a) levels in ischemic heart disease patients from SerbiaAngiotensin I-converting enzyme gene polymorphism in a Serbian population: a gender-specific association with hypertension
P50
Q24538957-49F21832-1E40-48D8-9804-438D76F3F30BQ37107031-04BDF7C9-0A99-49B2-A6CE-6EF650F24872Q37155373-31B8246D-7C17-4CD7-BDF4-9FEF68EE3FCCQ38445316-AF889CD7-B26B-4DCD-A586-7E2A5D8797ECQ38569644-C208BEA7-7308-4A2E-A093-7A0CB02813B7Q39341219-BADC9464-1BCF-4EBE-8A59-E5809FE7E894Q39887873-321DDFD0-4BBF-4885-8654-F2488D5FA7F7Q40840798-591B6348-4692-431F-A8D2-85255D0A6E91Q42198896-25010A0A-F8B8-4DD7-B64E-BA817551EE41Q42972042-ADBBE002-57D1-4E30-A6DA-A8B360DE7132Q42990744-3355BCE4-CA67-4C9B-B7FF-5090052DB72CQ43475985-105F0B1D-4E83-4045-944C-7A048772B2ECQ44923194-8B88822E-C599-4BB8-AD2D-5F42B8988326Q46948462-BEDFD4B4-7FE0-4F07-B082-2D15BBCFF0F4Q47643201-27681496-1B32-4B72-BB46-3F5248445AF0Q47653056-77C9CD73-81C2-457B-BA28-90905ECAD0B3Q47664674-743632A5-8291-4128-9A05-EF7A7877BDACQ47745902-6CD61E1C-F9C4-4AE5-926C-A387E050C05BQ50910667-866BD7BA-8AEC-4BCE-B72A-82446B453D85Q51138727-732F5347-152C-4FE1-B6AF-85FDAABC8B10Q51744778-E5093F45-6DE6-45BB-A7D0-2ED1E2F57F55Q51746575-BB3755F0-D266-4448-88C2-40E37AD2FBA5Q51831372-5DDBEF61-3CAB-4A87-945E-78A11DDCBBBEQ52582837-F915E2FE-9E5C-4E81-8C84-E6ED1839D745Q54349768-2BAE5EFF-74EF-4925-81F1-FC20B40CB0CCQ54439256-813129B6-7E94-4DE8-BB51-8846D23866A4Q54676412-81ABFF51-D475-4B7F-A2D8-A7C16F22A86AQ56901999-45D03924-9703-49C3-8DD3-F48994D8CE20Q57015034-542BF91C-5A8B-4252-A62E-FFDF02EFCD26Q57015040-02AF3800-1195-4CE7-9F9E-5959DB7D69D4Q57015044-C266B6A9-C302-4C17-8817-3BC4FB54DA81Q57015047-E63C4217-7E4D-48C9-83F5-C817A01E98AFQ59189096-E012D73E-F3F4-4DD2-8918-B3A047F4D38EQ59189102-B5CF18BE-8D26-41B7-89E5-D1E2FB9CBAA5Q59189179-95416DAC-F0A5-4353-9A92-DAAFAC2B085DQ59189181-3B3FE78C-4A08-4EA7-898B-F2AA27DE73A8Q59189201-490B23E0-6943-4504-8431-FD05C631229CQ59189206-A6606E9E-BB28-4267-B3F8-CA55C67497FCQ59189248-42FD6773-D9E5-4E8C-ACA9-AE86C9B690C0Q59189332-28F7E515-4741-4C21-9084-52948E203E73
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dragan Alavantic
@ast
Dragan Alavantic
@en
Dragan Alavantic
@es
Dragan Alavantic
@nl
Dragan Alavantic
@sl
type
label
Dragan Alavantic
@ast
Dragan Alavantic
@en
Dragan Alavantic
@es
Dragan Alavantic
@nl
Dragan Alavantic
@sl
prefLabel
Dragan Alavantic
@ast
Dragan Alavantic
@en
Dragan Alavantic
@es
Dragan Alavantic
@nl
Dragan Alavantic
@sl
P106
P1153
6604046863
P31
P496
0000-0001-5353-213X